The novel therapy of this peptide represents a major advance in the handling of type 2 diabetes. Different to existing medications, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide707302.ssnblog.com/40643576/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment